Heterozygous mutations of DNMT3A have been observed to lead to the development of myeloid leukaemias, implying that DNMT3A qualifies as a haploinsufficient tumour suppressor gene [110,112,113,114]. This evidence concerns the gene DNMT3A and myeloid leukemia.